Rajeev Singh Biography and Net Worth

CEO of Accolade

Rajeev Singh joined Accolade in November of 2015. Under his leadership, Accolade became a publicly traded company in 2020 and integrated four companies in over $1 billion in acquisitions. In 2022, Accolade launched Personalized Healthcare, a new category of healthcare.

Prior to Accolade, Singh co-founded Concur (Nasdaq: CNQR), the global leader in travel and expense management. Concur went public in 1998, growing to more than $800 million in revenue, over 4,000 employees, and more than 25,000 customers before being acquired by SAP AG for $8.3 billion in 2014. Singh was president, chief operating officer, and a member of the board of directors.

Singh graduated with a Bachelor of Science in Engineering from Western Michigan University.

What is Rajeev Singh's net worth?: The estimated net worth of Rajeev Singh is at least $5.84 million as of April 2nd, 2025. Mr. Singh owns 831,955 shares of Accolade stock worth more than $5,840,324 as of December 5th. This net worth evaluation does not reflect any other investments that Mr. Singh may own. Additionally, Mr. Singh receives a salary of $503,500.00 as CEO at Accolade. Learn More about Rajeev Singh's net worth.
How old is Rajeev Singh?: Mr. Singh is currently 56 years old. There are 4 older executives and no younger executives at Accolade. Learn More on Rajeev Singh's age.
What is Rajeev Singh's salary?: As the CEO of Accolade, Inc., Mr. Singh earns $503,500.00 per year. Learn More on Rajeev Singh's salary.
How do I contact Rajeev Singh?: The corporate mailing address for Mr. Singh and other Accolade executives is 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462. Accolade can also be reached via phone at 206-926-8100 and via email at [email protected]. Learn More on Rajeev Singh's contact information.
Has Rajeev Singh been buying or selling shares of Accolade?: Rajeev Singh has not been actively trading shares of Accolade during the last quarter. Most recently, Rajeev Singh sold 922 shares of the business's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $6.99, for a transaction totalling $6,444.78. Following the completion of the sale, the chief executive officer now directly owns 831,955 shares of the company's stock, valued at $5,815,365.45. Learn More on Rajeev Singh's trading history.
Who are Accolade's active insiders?: Accolade's insider roster includes Stephen Barnes (CFO), Robert Cavanaugh (President), Richard Eskew (Executive Vice President, General Counsel, Chief Compliance Officer), and Rajeev Singh (CEO). Learn More on Accolade's active insiders.
Are insiders buying or selling shares of Accolade?: During the last year, insiders at the sold shares 37 times. They sold a total of 16,651 shares worth more than $99,396.52. The most recent insider tranaction occured on April, 2nd when CFO Stephen H Barnes sold 431 shares worth more than $3,012.69. Insiders at Accolade own 8.2% of the company. Learn More about insider trades at Accolade.
Information on this page was last updated on 4/2/2025.

Rajeev Singh Insider Trading History at Accolade

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2025	Sell	922	$6.99	$6,444.78	831,955
3/18/2025	Sell	289	$6.99	$2,020.11	829,090
3/11/2025	Sell	490	$6.96	$3,410.40	828,447
3/4/2025	Sell	1,121	$6.96	$7,802.16	827,287
2/19/2025	Sell	279	$6.90	$1,925.10	824,622
2/11/2025	Sell	509	$6.88	$3,501.92	823,968
2/4/2025	Sell	1,170	$6.93	$8,108.10	822,827
1/17/2025	Sell	309	$6.86	$2,119.74	820,211
1/13/2025	Sell	541	$6.88	$3,722.08	819,588
1/3/2025	Sell	1,158	$3.41	$3,948.78	818,479
12/17/2024	Sell	381	$3.43	$1,306.83	815,851
12/11/2024	Sell	667	$3.62	$2,414.54	815,299
12/3/2024	Sell	13,357	$3.60	$48,085.20	814,316
11/19/2024	Sell	380	$3.35	$1,273.00	796,109
11/12/2024	Sell	668	$3.64	$2,431.52	795,556
11/4/2024	Sell	1,545	$3.15	$4,866.75	794,574
10/17/2024	Sell	385	$3.67	$1,412.95	792,333
10/11/2024	Sell	680	$3.77	$2,563.60	791,785
10/2/2024	Sell	1,540	$3.70	$5,698.00	790,815
9/17/2024	Sell	366	$4.32	$1,581.12	788,569
9/11/2024	Sell	672	$3.91	$2,627.52	788,002
9/4/2024	Sell	1,527	$4.22	$6,443.94	787,024
8/19/2024	Sell	373	$4.14	$1,544.22	784,765
8/13/2024	Sell	662	$3.90	$2,581.80	784,205
8/2/2024	Sell	1,590	$3.71	$5,898.90	783,217
7/17/2024	Sell	383	$3.86	$1,478.38	781,021
7/11/2024	Sell	649	$3.52	$2,284.48	780,472
7/2/2024	Sell	1,517	$3.54	$5,370.18	779,471
6/11/2024	Sell	690	$6.45	$4,450.50	749,836
5/17/2024	Sell	376	$7.27	$2,733.52	748,876
5/13/2024	Sell	640	$7.44	$4,761.60	748,319
4/18/2024	Sell	355	$8.82	$3,131.10	747,309
4/11/2024	Sell	667	$8.85	$5,902.95	746,731
3/19/2024	Sell	376	$9.48	$3,564.48	745,748
3/12/2024	Sell	662	$9.52	$6,302.24	745,191
2/13/2024	Sell	705	$13.03	$9,186.15	743,656
1/17/2024	Sell	383	$12.86	$4,925.38	742,711
1/11/2024	Sell	21,530	$15.02	$323,380.60	742,162
1/9/2024	Sell	36,199	$15.00	$542,985.00	705,083
12/19/2023	Sell	366	$10.89	$3,985.74	741,282
12/12/2023	Sell	677	$9.23	$6,248.71	740,715
11/17/2023	Sell	358	$7.94	$2,842.52	739,742
11/13/2023	Sell	666	$6.99	$4,655.34	739,166
10/17/2023	Sell	371	$7.22	$2,678.62	588,183
10/11/2023	Sell	659	$8.63	$5,687.17	587,621
9/19/2023	Sell	378	$11.81	$4,464.18	586,630
9/12/2023	Sell	662	$13.23	$8,758.26	586,075
8/18/2023	Sell	377	$13.03	$4,912.31	585,087
8/11/2023	Sell	657	$14.05	$9,230.85	584,531
7/18/2023	Sell	364	$14.16	$5,154.24	583,538
7/11/2023	Sell	655	$12.68	$8,305.40	582,970
6/20/2023	Sell	373	$13.42	$5,005.66	581,975
6/13/2023	Sell	7,622	$13.81	$105,259.82	581,415
5/26/2023	Sell	1,512	$11.38	$17,206.56	569,238
5/24/2023	Sell	1,456	$11.82	$17,209.92	564,205
5/22/2023	Sell	1,578	$10.90	$17,200.20	559,136
5/17/2023	Sell	230	$10.47	$2,408.10	156,573
4/18/2023	Sell	220	$14.58	$3,207.60	155,870
2/17/2023	Sell	282	$11.95	$3,369.90	154,516
1/18/2023	Sell	276	$9.96	$2,748.96	153,865
12/19/2022	Sell	230	$8.43	$1,938.90	153,209
11/17/2022	Sell	239	$8.59	$2,053.01	152,506
10/17/2022	Sell	216	$11.03	$2,382.48	151,812
9/19/2022	Sell	232	$12.27	$2,846.64	151,095
8/17/2022	Sell	236	$12.19	$2,876.84	150,394
8/2/2022	Buy	17,500	$10.09	$176,575.00	149,697
7/18/2022	Sell	222	$9.49	$2,106.78	55,202
6/17/2022	Sell	2,602	$5.66	$14,727.32	54,492

Rajeev Singh Buying and Selling Activity at Accolade

Accolade Company Overview

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Today's Range

Now: $7.02

$7.02

50 Day Range

MA: $7.02

$7.02

2 Week Range

Now: $7.02

$3.08

$7.03

Volume

N/A

Average Volume

1,482,373 shs

Market Capitalization

$575.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1

Rajeev Singh Biography and Net Worth

What is Rajeev Singh's net worth?

How old is Rajeev Singh?

What is Rajeev Singh's salary?

How do I contact Rajeev Singh?

Has Rajeev Singh been buying or selling shares of Accolade?

Who are Accolade's active insiders?

Are insiders buying or selling shares of Accolade?

Rajeev Singh Insider Trading History at Accolade

Rajeev Singh Buying and Selling Activity at Accolade

Accolade Company Overview

Today's Range

50 Day Range

2 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta